USPTO serial 98046823
TAP
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- HOWELL, MATTHEW P
- Law office
- TMO LAW OFFICE 123
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with TAP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $896*
Plus Government fees of $500
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
ERICA D. KLEIN
ERICA D. KLEIN BROOKS KUSHMAN P.C.1000 TOWN CENTER, 22ND FLOORSOUTHFIELD, MI 48075United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological, medicinal and pharmaceutical preparations, namely, therapeutic pharmaceutical for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, therapeutic agents in the nature of therapeutic pharmaceutical for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, therapeutic vaccines for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, biological preparations for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, biological agents being biological preparations for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, biological vaccines for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, medicinal preparations for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, medicinal agents being medicinal preparations for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, medicinal vaccines for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, pharmaceutical agents in the nature of pharmaceutical preparations for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; biological, medicinal and pharmaceutical preparations, namely, pharmaceutical vaccines for the treatment of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; diagnostic preparations for medical and clinical laboratory use being for medical purposes; dietetic preparations, namely, nutritional supplements based on vitamins, minerals and probiotics; chemicals for use in medical laboratories, namely, diagnostic chemicals in the nature of diagnostic preparations for medical use, diagnostic agents for medical use, and diagnostic vaccines for medical use | ACTIVE | — |
| 009 | Downloadable computer software platform for publicizing studies, research initiatives, fundraising activities and networking, and providing interactive matching services between research groups and contributors; downloadable computer software and downloadable computer applications for presenting, organizing, and sharing data and information in the fields of studies, research initiatives, fundraising activities and networking | ACTIVE | — |
| 042 | Platform as a service (PAAS) featuring computer software platforms for publicizing studies, research initiatives, fundraising activities and networking; software as a service (SAAS) services featuring software for the collection, organizing, and sharing of data and information in the fields of studies, research initiatives, fundraising activities and networking; product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services, namely, scientific research consulting being research, design, testing and clinical trials in the field of scientific research in the pharmaceutical industry; industrial analysis in the nature of product testing, product research and industrial research in the fields of pharmaceuticals, biopharmaceuticals, health care products and medical products; pharmaceutical drug development services and biopharmaceutical drug development services being pharmaceutical drug development services; pharmaceutical research and development and biopharmaceutical research and development services being pharmaceutical drug development services; product development consultation; product research services in the nature of providing analytical testing, biosafety testing, reporting and laboratory services for others; scientific and technical product development consulting and research services for the pharmaceutical industry, namely, product development consultation; custom design and development of chemical reagents and biochemical assays; scientific research and development services in the field of cancer immunotherapy; medical and scientific research, namely, conducting clinical trials for others in the field of cancer immunotherapy; planning and executing projects in the area of the supply of pharmaceuticals, namely, development of pharmaceutical substances in the nature of pharmaceutical research and development; providing information about medical and scientific research being experience-based knowledge, information and consulting services in high throughput screening of chemicals during chemical analysis, chemical synthesis, toxicological and pharmaceutical research, genome target identification and validation; product development consultation services being consulting services in production and development in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products, animal and human pharmacokinetic evaluations; consulting services in the nature of providing clinical development concepts, namely, scientific research; providing scientific research information in the field of chemicals, pharmaceuticals, diagnostic and laboratory products as well as biochemical, biological, chemical, immunochemical and immunological compositions and preparations provided through a website and distributed via global computer network; platform as a service (PAAS) featuring computer software platforms for providing scientific research information, medical terminology, medical and pharmaceutical data, and scientific, medical and pharmaceutical counseling information; drawing up scientific, medical and pharmaceutical expert reports, documents and information, namely, providing a website featuring technology that enables physicians, scientists, patients, clinical trial participants and research participants to generate, manage and exchange medical information and documents regardless of medical organization or geographic location; planning, performing and evaluating scientific studies, namely, scientific research consulting being scientific studies in the field of science and medical research; counseling with regard to ensuring drug safety and services in the nature of providing respective information to patients, doctors and clients, namely, scientific research consulting being compiling, analyzing and disseminating data for science and medical use; services rendered in the laboratory and chemical area in the nature of development of analytical methods and drug master files, reviewing standards and practices to assure compliance with pharmaceutical application and regulation requirements and consultation in the area of upscaling of laboratory processes, namely, providing scientific and medical research information; consulting services rendered in the medical, pharmaceutical, and pharma-economy sector, namely, scientific research consulting; services relating to pharmaceutical preparations, namely, medical research services; providing online non-downloadable computer software platform for publicizing studies, research initiatives, fundraising activities and networking, and providing interactive matching services between research groups and contributors; providing online non-downloadable computer software for presenting, organizing, and sharing data and information in the fields of studies, research initiatives, fundraising activities and networking; providing scientific research information in the field of therapeutic pharmaceutical research, medical research, and scientific research | ACTIVE | — |
| 044 | Providing healthcare information; counseling with regard to ensuring drug safety and services in the nature of providing respective information to physicians, scientists, patients, clinical trial participants and research participants, namely, clinical medical consultation services; services relating to pharmaceutical preparations, pharmaceutical agents, pharmaceutical vaccines, biological preparations, biological agents, biological vaccines, medicinal preparations, medicinal agents and medicinal vaccines, namely, healthcare; providing medical advice in the fields of infertility, genetic diseases and disorders, viral diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases and disorders, cardiomyopathies, heart muscle diseases and disorders, muscular dystrophies, muscle atrophy, genitourinary diseases and disorders, sexual dysfunction, oncological diseases, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders, psychiatric diseases and disorders, and immune system related diseases and disorders; health care services, namely, healthcare being disease identification programs, disorder identification programs, disease management programs, disorder management programs, disease treatment programs and disorder treatment programs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DECENT HEALTH HOLDINGS LLC
- Other trademarks owned by DECENT HEALTH HOLDINGS LLC
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TAP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 7, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 6, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 6, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 4, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 3, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 3, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 3, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 6, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2025 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 14, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2024 | ALIE | ASSIGNED TO LIE | — |
| Aug 12, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 12, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Aug 12, 2024 | PETG | PETITION TO REVIVE-GRANTED | — |
| Aug 12, 2024 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jun 24, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 24, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 8, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 8, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 8, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 20, 2023 | NWAP | NEW APPLICATION ENTERED | — |